U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Medical Devices
  5. Medical Devices Advisory Committee
  6. Orthopaedic and Rehabilitation Devices Panel
  7. Roster of the Orthopaedic and Rehabilitation Devices Panel
  1. Orthopaedic and Rehabilitation Devices Panel

Roster of the Orthopaedic and Rehabilitation Devices Panel

Purpose: The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational orthopedic and rehabilitation devices and makes appropriate recommendations to the Commissioner of Food and Drugs.

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies: 4

Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson
Harvey E. Smith, M.D.
Expertise: Neurosurgery
Term: 09/30/2016 – 08/31/2024
Assistant Professor of Neurosurgery
Department of Orthopaedic Surgery
University of Pennsylvania School of Medicine
3737 Market Street 6th Floor
Philadelphia, PA 19104

Designated Federal Officer
Akinola Awojope, Dr.PH.
Center for Devices and Radiological Health
Office of Management
10903 New Hampshire Avenue
WO Bldg. 66, Rm 5216
Silver Spring, MD 20993
Office: (301) 636-0512
Fax: (301) 847-8505

Lynda J. Yang, M.D., Ph.D.
Expertise: Neurosurgery
Term: 12/01/2016 to 08/31/2022
Professor, Dept. of Neurosurgery
University of Michigan
1500 E. Medical Center Dr., SPC 5338
Ann Arbor, MI 48109

Maureen A. Finnegan, M.D.
Expertise: Joints and Sports Medicine
Term: 09/01/2018 - 08/31/2022
Associate Professor
Dept. of Orthopaedic Surgery
Univ. Texas Southwestern Medical Center
1801 Inwood Rd.
Dallas, TX 75390-8883

Brent A. Blumenstein, PhD
Expertise: Biostatistics
Term: 11/22/2019 – 08/31/2023
Principal Consultant
Trial Architecture Consulting
Chevy Chase, MD 20815

Stacey E. Bonnell, M.B.A., RAC **
Expertise: Regulatory Affairs
Term: 09/01/2020 to 08/31/2024
Global Leader, Regulatory Affairs
Nuvasive, Inc.
7475 Lusk Boulevard
San Diego, CA 92121

 

* Consumer Representative
** Industry Representative

Back to Top